
April 1 (Reuters) - Lyell Immunopharma Inc LYEL.O:
LYELL IMMUNOPHARMA INC - TO CLOSE WEST HILLS MANUFACTURING FACILITY - SEC FILING
LYELL IMMUNOPHARMA INC - TO REDUCE WORKFORCE BY 73 EMPLOYEES IN WEST HILLS - SEC FILING
LYELL IMMUNOPHARMA INC - EXPECTS $3M-$4M EXPENSES FROM WORKFORCE REDUCTION - SEC FILING
LYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER PRODUCING IMPT-314 FOR PHASE 1/2 TRIAL - SEC FILING
LYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER EXPECTED TO MEET DRUG SUPPLY NEEDS - SEC FILING
LYELL IMMUNOPHARMA INC: REITERATES ITS FINANCIAL GUIDANCE
Source text: [ID:n0001193125-25-070521]